Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Mental health conditions

Pharmacist awarded £350k to improve adherence in bipolar disorder

Asta Prajapati is the first mental health pharmacist in England to receive this type of grant.

Asta Prajapati, pharmacist

Source: Courtesy, Asta Prajapati

Asta Prajapati hopes his grant to improve medicine adherence in patients with bipolar disorder will inspire future generations of mental health pharmacists to compete for this award

A mental health pharmacist is the first ever to receive a Health Education England/National Institute of Health Research Clinical Doctoral Research Fellowship Funding Award to develop a tool to identify patients struggling to take their medicines as prescribed.

Asta Prajapati, a consultant pharmacist at Norfolk and Suffolk NHS Foundation Trust, received a £350,000 grant to improve medicines adherence in patients with bipolar disorder.

He will develop the tool as part of his PhD at the University of East Anglia (UEA), leading a multidisciplinary team including psychiatrists, health psychologists, patients and carers.

“The tool will be underpinned by the Theoretical Domains Framework (TDF), which draws together many different psychological theories into one framework and has successfully informed the development of several behaviour change interventions,” said Prajapati.

It will be tested on around 600 patients with bipolar disorder, will help identify patients who are struggling to take their medicines as prescribed, and their individual reasons will be mapped to the domains of TDF. 

“This will allow provision of patient-centred individualised support to improve adherence and, thereby, patient outcome,” he said. 

Bipolar disorder is associated with significant disability, functional impairment and use of NHS resources, said Prajapati, and around 40% of patients with bipolar disorder do not take their medication as prescribed, leading to difficulties in daily life, greater likelihood of hospitalisation, and higher risk of suicide.

“I was absolutely delighted when I heard I had been awarded the funding,” he said. 

“Hopefully this will inspire future generations of mental health pharmacists to consider competing for this award.

“I am very excited to start this research to help our patients receive the best from their medications — the project has the potential to make a real difference in our patients.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204953

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Asta Prajapati, pharmacist

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.